BIOL - Biolase Inc
Previous close
0.053
0 0%
Share volume: 894,472
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$0.05
0.00
0.00%
Summary score
30%
Profitability
28%
Dept financing
25%
Liquidity
24%
Performance
35%
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Long-term ratios 2019 - 2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
1.48%
Return on assets
-12.11%
Return on sales
-57.74%
Return on invested capital
72.88%
Total debt ratio
72.96%
Debt ratio change over timeo
0.68%
Current Ratio
2.54%
Quick Ratio
1.66%
Cash Position Ratio
1.18%
Short-term ratios 2022 - 2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-88.85%
Return on assets
-15.62%
Return on sales
-53.88%
Return on invested capital
107.23%
Total debt ratio
73.23%
Debt ratio change over timeo
-0.2%
Current Ratio
2.24%
Quick Ratio
1.18%
Cash Position Ratio
0.68%
Last quarter ratios 2023
The data are presented for the financials results of the last quarter.
Return on equity
-71.7%
Return on assets
-12.61%
Return on sales
-50.55%
Return on invested capital
64.85%
Total debt ratio
80.55%
Debt ratio change over time
-0.28%
Current Ratio
1.68%
Quick Ratio
0.75%
Cash Position Ratio
0.34%
Performance ratios (change over 4 years) 2019 - 2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
141.09%
Return on assets
-126.31%
Return on sales
-221.02%
Return on invested capital
12.89%
Total debt ratio
68.14%
Debt ratio change over time
0.68%
Current Ratio
5.36%
Quick Ratio
3.35%
Cash Position Ratio
2.23%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | BIOL | ABT | ISRG | SYK |
---|---|---|---|---|
Return on equity | 1.48% | 4.19% | 3.46% | 3.62% |
Return on assets | -12.11% | 2.37% | 3.22% | 2.22% |
Return on sales | -57.74% | 17.13% | 27.5% | 17.43% |
Return on invested capital | 72.88% | 3.73% | 7.32% | 2.83% |
Profitability | 34% | 60% | 73% | 56% |
Total debt ratio | 72.96% | 53.07% | 13.24% | 57.19% |
Debt ratio change over time | 0.68% | 17.94% | 1.1% | 12.72% |
Dept financing | 26% | 43% | 6% | 37% |
Current Ratio | 2.24% | 1.79% | 5.03% | 1.85% |
Quick Ratio | 1.18% | 1.35% | 4.37% | 1.08% |
Cash Position Ratio | 0.68% | 0.7% | 3.44% | 0.3% |
Liquididy | 28% | 18% | 75% | 21% |
Short-term ratios | BIOL | ABT | ISRG | SYK |
---|---|---|---|---|
Return on equity | -88.85% | 3.98% | 2.87% | 4.01% |
Return on assets | -15.62% | 2.36% | 2.94% | 2.27% |
Return on sales | -53.88% | 16.63% | 24.27% | 17.46% |
Return on invested capital | 107.23% | 4.12% | 6% | 3.05% |
Profitability | 25% | 63% | 69% | 63% |
Total debt ratio | 73.23% | 50.6% | 13.6% | 54.96% |
Debt ratio change over time | -0.2% | 11.83% | 1.29% | 17.29% |
Dept financing | 25% | 34% | 7% | 44% |
Current Ratio | 2.24% | 1.79% | 5.03% | 1.85% |
Quick Ratio | 1.18% | 1.35% | 4.37% | 1.08% |
Cash Position Ratio | 0.68% | 0.7% | 3.44% | 0.3% |
Liquididy | 23% | 22% | 75% | 18% |